REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/27/2026
Back to search
Official data from USPTO
COMPREHENSIVE CELL SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COMPREHENSIVE CELL SOLUTIONS
ST13
US500000086881963Class
35, 39, 40, 42, 44
Filing
86881963
Registration
5234078
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/27/2026
Trademark type
Word
Nice classes
35, 39, 40, 42, 44
Filing date
01/21/2016
Registration date
06/27/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/20/2024
Last transaction
06/27/2026
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Supplemental Register
First use anywhere
02/11/2016
First use in commerce
02/11/2016
Drawing code
4
Owner type
03
Owner location
New York, NY, US
Examiner
BUSH, KAREN K
Law office
L80
Holders and representatives
Holders
New York Blood Center, Inc.
Representatives
CYNTHIA JOHNSON WALDEN FISH & RICHARDSON P.C.
Technical classification
Nice Classes
Class 35Class 39Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Services to support and manage transfusion medicineregenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinicproviding independent review of clinical trials for business purposes
Class 39
Services to support and manage transfusion medicineregenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinicnamely storage of blood and stem cells
Class 40
Services to support and manage transfusion medicineregenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the cliniccryopreservation of human cells
Class 42
Services to support and manage transfusion medicineregenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinicmedical laboratory and research and pharmaceutical research services and pharmaceutical clinical trials for others
Class 44
Services to support and manage transfusion medicineregenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinictissue bank services; cell processing services for use by others; stem cell storage; collection and preservation of human bloodapheresisred blood cellsplasma and bone marrow
Publications
History of USPTO decisions and trademark events.
31 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/06/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/06/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/06/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/20/2024
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
02/20/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/20/2024
ES8R
TEAS SECTION 8 RECEIVED
12/22/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/27/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/27/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/23/2017
ALIE
ASSIGNED TO LIE
05/22/2017
ALIE
ASSIGNED TO LIE
05/10/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/17/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/13/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/12/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/18/2016
GNFR
FINAL REFUSAL E-MAILED
11/18/2016
CNFR
FINAL REFUSAL WRITTEN
11/18/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/26/2016
GNRT
NON-FINAL ACTION E-MAILED
04/26/2016
CNRT
NON-FINAL ACTION WRITTEN
04/26/2016
DOCK
ASSIGNED TO EXAMINER
04/20/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/27/2016
NWAP
NEW APPLICATION ENTERED
01/25/2016
Continuous trademark protection
Get notified about every new filing that threatens COMPREHENSIVE CELL SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.